Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
NPCE · against 435 other Healthcare companies of similar size
Ranked #416 of 436 · scores higher than 5% of peers · safety percentile 5
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)45 peers with a safety percentile of 0–9, including NPCE · Click a bar to see the companies
Mainly because of its debt / equity and beta, which are weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | NPCE | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 403 reported | 5.88× | 0.18× | 2% | 33% | |
| BetaLower is better · 418 reported | 1.87 | 0.46 | 6% | 33% | |
| Current ratioHigher is better · 429 reported | 4.94× | 2.91× | 69% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 421M USD | 99 | 52 | |
| 2 | 261M USD | 99 | 97 | |
| 3 | 397M USD | 99 | 37 | |
| 4 | 455M USD | 99 | 53 | |
| 5 | 2.7B CNY (≈$375M) | 99 | 67 | |
| 412 | 773M USD | 6 | 64 | |
| 413 | 296M USD | 5 | 66 | |
| 414 | 222M GBP (≈$288M) | 5 | 13 | |
| 415 | 3.7B CNY (≈$520M) | 5 | 42 | |
| 416 | 423M USD | 5 | 29 | |
| 417 | 356M USD | 4 | 35 | |
| 418 | 486M USD | 4 | 16 | |
| 419 | 684M USD | 4 | ||
| 420 | 758M USD | 4 | 35 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score